Table 3 Schedule of observation and procedures

Check eligibility against inclusion/exclusion criteria and medication review

X

Screening for S. aureus colonization

X

X

X

X

X

Gartering informed consent and randomization

X

Sociodemographic and lifestyle data^a

X

Medical history by Charlson comorbidity index and ESKD etiology

X

Physical examination

X

X

X

X

X

X

X

X

X

X

PD-related infection: dialysate characteristics and exit-site assessment

X

X

X

X

X

X

X

X

X

Routine laboratory tests (performed locally)^b

X

X

X

X

X

X

X

X

X

Dialysate adequacy and peritoneal equilibration test

X

X

X

HRQOL and mental health^c

X

X

X

X

X

Record medication changes

X

X

X

X

X

X

X

X

X

Safety profiles: skin reactions and adverse events documentation

X

X

X

X

X

X

X

X

X

X

Hospitalization and emergency visit

X

X

X

X

X

X

X

X

X

Assess adherence with trial treatment allocation and other medication^d

X

X

X

X

X

X

X

X

Healthcare costs: direct medical cost, direct non-medical cost, and indirect cost

X

X

X

Data monitoring

X

X

X

X

X

X

X

X

Statistical analysis and reporting

X

X